Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
ABH Healthcare Ltd (ABH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: ABH Hospital & Healthcare Services | Small Cap | ABH Healthcare Share Price
BSE Share Price
Not Listed
Not Listed
ABH Healthcare Ltd (ABH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: ABH Hospital & Healthcare Services | Small Cap | ABH Healthcare Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹72 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹4.9
TTM Sales
₹52.5 Cr.
Book Value per Share
₹18.2
P/E Ratio
12.69
Lower than its 5-year historical median
Industry PE
99.8
Price to Book (P/B)
3.45
Lower than its 5-year historical median
Price to Sales (P/S)
1.36
Lower than its 5-year historical median
EV/EBITDA
8.36
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
38.85%
Outperforms industry median
Return on Capital Employed (ROCE)
19.71%
Outperforms industry median
Return on Assets (ROA)
7.42%
Operating Profit Margin
28.3%
Net Profit Margin
10.74%
Gross Profit Margin
19.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
18.22%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
11.52%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
5.42%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹9 Cr.
Equity
₹11.4 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is ABH Healthcare Ltd a good quality company?
ABH Healthcare Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does ABH Healthcare Ltd performance compare with that of its Peers?
Revenue growth of ABH Healthcare Ltd vs industry peers?
ABH Healthcare Ltd revenue CAGR is 140.88%, compared to the industry median CAGR of 10.53%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of ABH Healthcare Ltd?
Promoters hold % of the ABH Healthcare Ltd, with % of their stake pledged, indicating no pledge risk.
Stock return of ABH Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
ABH Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|
| ROCE % ⓘ | 1% | 10.7% | 14.9% | 23.3% | - |
| Value Creation Index ⓘ | -0.9 | -0.2 | 0.1 | 0.7 | - |
Growth Parameters ⓘ |
|||||
| Sales ⓘ | 3.5 | 28.5 | 41.4 | 48.9 | 49 |
| Sales YoY Gr. | - | 714.6% | 45.1% | 18.2% | - |
| Adj EPS ⓘ | 4.1 | 0.9 | 2.7 | 6.6 | 4.6 |
| YoY Gr. | - | -77.2% | 189.4% | 141.9% | - |
| BVPS (₹) ⓘ | 6.6 | 6 | 7.9 | 14.5 | 18.4 |
| Adj Net Profit ⓘ | 0.2 | 0.8 | 2.2 | 5.3 | 5 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0.9 | 2.7 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 40.3 | 15 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 140.9% | 18.2% | ||||
| Adj EPS ⓘ | NA | NA | 16.9% | 141.9% | ||||
| BVPSⓘ | NA | NA | 29.9% | 82.9% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|
| Return on Equity % ⓘ | 62.3 | 29.7 | 38.9 | 58.6 | 28 |
| Op. Profit Mgn % ⓘ | 6.4 | 10.9 | 18.5 | 26.7 | NAN |
| Net Profit Mgn % ⓘ | 4.7 | 2.7 | 5.3 | 10.8 | 10.8 |
| Debt to Equity ⓘ | 82 | 4.7 | 5.6 | 3.5 | - |
| Working Cap Days ⓘ | 0 | 84 | 122 | 170 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 19 | 52 | 83 | 0 |
Valuation of ABH Healthcare - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
No Data To Display
Promoter's Holding & Share Pledging
Financials
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Sales | 3.50 | 29.61 | 41.38 | 49.27 | 52.51 |
| Operating Expenses ⓘ + | 3.26 | 25.56 | 34.49 | 36.07 | 37.79 |
| Operating Profit ⓘ | 0.24 | 4.05 | 6.89 | 13.20 | 14.72 |
| Operating Profit Margin (%) | 6.8% | 13.7% | 16.7% | 26.8% | 28.0% |
| Other Income ⓘ + | 0 | 0 | 0.01 | 0.05 | 0.08 |
| Interest ⓘ | 0.04 | 1.33 | 2.96 | 3.71 | 4.48 |
| Depreciation ⓘ | 0.07 | 1.56 | 1.74 | 2.10 | 2.39 |
| Profit Before Tax ⓘ | 0.12 | 1.16 | 2.21 | 7.43 | 7.93 |
| Tax ⓘ | 0.04 | 0.45 | 0.55 | 2.08 | 2.29 |
| Profit After Tax | 0.09 | 0.71 | 1.66 | 5.35 | 5.64 |
| PAT Margin (%) | 2.4% | 2.4% | 4.0% | 10.9% | 10.7% |
| Adjusted EPS (₹) | 2.1 | 0.9 | 2.1 | 6.7 | 7.1 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 0.19 | 4.70 | 6.35 | 11.69 | 17.34 | ||||||
| Debt + | 17.95 | 18.19 | 31.53 | 38.12 | 52 | ||||||
| Minority Interest | 0 | 0 | 0 | 0.01 | 0 | ||||||
| Trade Payables | 4.03 | 4.91 | 5.57 | 6.78 | 6.60 | ||||||
| Others Liabilities ⓘ | 4.09 | 5.37 | 8.41 | 8.53 | 10.86 | ||||||
| Total Liabilities ⓘ | 26.25 | 33.17 | 51.87 | 65.13 | 86.79 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 23.48 | 22.73 | 33.81 | 36.68 | 41.92 | ||||||
| CWIP ⓘ | 0 | 0.63 | 0 | 0 | 0 | ||||||
| Investments ⓘ | 0 | 0 | 0.12 | 0.29 | 1.74 | ||||||
| Inventories | 2.01 | 2.26 | 2.89 | 4.46 | 3.25 | ||||||
| Trade Receivables | 0.23 | 5.89 | 11.98 | 19.74 | 33.11 | ||||||
| Cash Equivalents | 0.22 | 0.15 | 0.02 | 0.61 | 3.03 | ||||||
| Others Assets ⓘ | 0.32 | 1.51 | 3.05 | 3.36 | 3.74 | ||||||
| Total Assets ⓘ | 26.25 | 33.17 | 51.87 | 65.13 | 86.79 | ||||||
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 3.06 | -1.55 | 0.89 | 3.54 | 2.11 |
| Cash Flow From Investing Activity ⓘ + | -23.55 | -1.45 | -13.06 | -4.53 | -9.14 |
| Cash Flow From Financing Activity ⓘ + | 20.70 | 2.94 | 12.04 | 1.58 | 9.45 |
| Net Cash Flow ⓘ | 0.22 | -0.06 | -0.14 | 0.59 | 2.42 |
| PARTICULARS | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 45.95 | 29.18 | 29.97 | 59.26 | 38.85 | |||||
| ROCE (%) | 0.8 | 10.7 | 15.23 | 23.28 | 19.71 | |||||
| Asset Turnover Ratio | 0.13 | 1 | 0.97 | 0.84 | 0.69 | |||||
| PAT to CFO Conversion(x) | 34 | -2.18 | 0.54 | 0.66 | 0.37 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 23.90 | 37.70 | 78.80 | 117.50 | 183.70 | |||||
| Inventory Days | 209.50 | 26.30 | 22.70 | 27.20 | 26.80 | |||||
| Payable Days | 3,426.50 | 201.60 | 169 | 220.10 | 241.60 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
ABH Healthcare Ltd FAQs
The current trading price of ABH Healthcare on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of ABH Healthcare stood at ₹71.66 Cr
The latest P/E ratio of ABH Healthcare as of 31-Dec-1969 is 13.61.
The latest P/B ratio of ABH Healthcare as of 31-Dec-1969 is 3.40.
The 52-week high of ABH Healthcare is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of ABH Healthcare is ₹48.92 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that ABH Healthcare Ltd is a below average quality company.
The key valuation ratios of ABH Healthcare Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of ABH Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About ABH Healthcare Ltd
ABH Healthcare was originally incorporated as a private limited company in the name and style of ‘ABH Healthcare Private Limited’ on March 2, 2021. Further, in accordance with the main objects, the company acquired the sole proprietorship concern of Dr. Kamal Baghi, its Promoter in the name ‘Anil Baghi Hospital’ pursuant to a Business Transfer Agreement dated March 16, 2022. Subsequently, the company was converted from a private limited company to a public limited company, pursuant to a resolution passed in the Extraordinary general meeting of its members held on October 7, 2024 and consequently, the name of the company was changed to ‘ABH Healthcare Limited’, and a fresh certificate of incorporation consequent upon conversion dated November 15, 2024 was issued by the Registrar of Companies, Chandigarh.
Its core focus is on providing specialised tertiary medical care in Tier 3 cities, within the state of Punjab while seeking to strike a balance between providing quality healthcare services and affordability. Acquired by the company in 2022, the hospital was established in 1985 with 30 beds and is driven by a vision to provide affordable, accessible, and quality healthcare services. Since its acquisition, it has consistently invested in the hospital, expanding bed capacity, increasing its workforce, and introducing additional services and clinical specialties. It offers several medical specialties such as, cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, obstetrics and gynecology, orthopedics and joint replacement, neuro-psychiatry and drug de-addiction, general surgery, dentistry, physiotherapy, radiology, etc.
Business area of the company
The company is engaged in the business of establishing, maintaining, assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services.
Awards and recognitions
- 2022: Anil Baghi Hospital was honored to be recognized as the Number 1 hospital in Punjab among 715 hospitals empanelled with the State Health Agency, Punjab, and the National Health Authority.
- 2024: Anil Baghi Hospital is among the first 100 hospitals in India to be accredited with NABH Digital Standards - Silver Category.
History and milestones
- 2021: Incorporated as ‘ABH Healthcare Private Limited’.
- 2022: Acquisition of sole proprietorship concern Anil Baghi Hospital through Business Transfer Agreement dated March 16, 2022.
- 2024: The company converted to public limited company and consequently a change of name from ‘ABH Healthcare Private Limited’ to ‘ABH Healthcare Limited’.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
